Clinical Trials of Cancer Immunotherapies

Abstract A021: Vaccination with autologous, nonattenuated, live glioblastoma cells induces potent peripheral and intratumoral anti-tumoral responses: A first-in-human study

Pub Date : 2019-02-01 DOI: 10.1158/2326-6074.CRICIMTEATIAACR18-A021 I. Volovitz, N. Shapira, R. Grossman, Z. Ram

Abstract A001: Phase I study of vaccine therapy with a cocktail of peptides for pediatric patients with refractory solid tumors

Pub Date : 2019-02-01 DOI: 10.1158/2326-6074.CRICIMTEATIAACR18-A001 Yu Akazawa, A. Hosono, T. Yoshikawa, Hideo Kaneda, J. Hara, Y. Kinoshita, Kenichi Kohashi, A. Manabe, Y. Shioda, K. Shoda, M. Shimomura, S. Mizuno, Y. Nakamoto, T. Nakatsura

Abstract A020: Immunomonitoring for actively personalized peptide vaccines (APVACs) during immunotherapeutic treatment of glioblastoma

Pub Date : 2019-02-01 DOI: 10.1158/2326-6074.CRICIMTEATIAACR18-A020 Alexander Ulges, N. Hilf, W. Wick, M. Plattén, P. Dietrich, K. Frenzel, A. Admon, S. H. Burg, A. Deimling, P. Straten, C. Gouttefangeas, J. Kroep, F. Martínez-Ricarte, H. Okada, C. Ottensmeier, B. Ponsati, H. Poulsen, S. Stevanović, G. Tabatabai, H. Rammensee, U. Şahin, D. Maurer, R. Mendrzyk